Meeting
2024 ASCO Breakthrough
Racial impact of secondary metastasis in patients with lung cancer: Evidence of US hospitals in 2020.
Authors
Thanathip Suenghataiphorn
Griffin Hospital, Derby, CT
Thanathip Suenghataiphorn , Narathorn Kulthamrongsri , Sakditad Saowapa , Piengpitch Naunsilp , Nutchapon Xanthavanij , Soravis Alm Osataphan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Thoracic Cancers,Breast Cancer,Gynecologic Cancer,Head and Neck Cancer,Hematologic Malignancies,Genetics/Genomics/Multiomics,Healthtech Innovations,Models of Care and Care Delivery,Viral-Mediated Malignancies,Other Malignancies or Topics
Sub Track
Real-World Evidence/Real-World Data
Citation
J Clin Oncol 42, 2024 (suppl 23; abstr 213)
DOI
10.1200/JCO.2024.42.23_suppl.213
Abstract #
213
Poster Bd #
K8
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Nationwide analysis of patients with ovarian cancer: Racial status and risk of metastasis.
First Author: Thanathip Suenghataiphorn
Poster
2024 ASCO Annual Meeting
A two-decade trend analysis of in-hospital outcomes and racial/ethnic disparities among hospitalized patients with lung cancer in the United States.
First Author: Ted Akhiwu
Poster
2023 ASCO Annual Meeting
Impact of SARS-COV2 infection on the clinical outcomes in patients with lung cancer compared to all other cancers.
First Author: Vaishali Deenadayalan
Poster
2022 ASCO Quality Care Symposium
Racial and gender disparities in metastatic lung and bronchial cancer (LC) across the United States.
First Author: Devashish Desai